• Profile
Close

Effects of switching to a heat-not-burn tobacco product on biologically relevant biomarkers to assess a candidate modified risk tobacco product: A randomized trial

Cancer Epidemiology, Biomarkers & Prevention Sep 25, 2019

Lüdicke F, Ansari SM, Lama N, et al. - Assuming that heating instead of burning tobacco can lower the risk of chronic diseases associated with cigarette smoking, researchers examined cigarette smokers switching to the heat-not-burn Tobacco Heating System 2.2 (THS) for favorable changes in eight co-primary endpoints (HDL-C, WBC, FEV1%pred, COHb, Total NNAL, sICAM-1, 11-DTX-B2, and 8-epi-PGF2α) indicative of biological and functional effects. Additionally, they determined the following biomarkers of exposure (BoExp): MHBMA, 3-HPMA, Total NNN, CEMA, 3-OH-B[a]P, HMPMA, Total 1-OHP, NEQ, and CO exhaled. They randomized participants to either continue smoking their preferred cigarette brand (n = 496) or use THS (IQOS brand; n = 488) for 6 months. They observed similar nicotine levels in both groups. Smokers who predominantly used THS vs those who continued cigarette smoking had favorable changes in all endpoints, which were in line with smoking cessation, and had improved biological effects.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay